Argent Biopharma Ltd

RGT

Company Profile

  • Business description

    Argent Biopharma Ltd is a drug discovery company that addresses unmet medical needs. The company focuses on multidisciplinary methods with nanotechnology, developing multi-target therapies for comprehensive disease management, especially in the central nervous system and immunology treatments. The products of the company include CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury, and ARDS, and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development, and others.

  • Contact

    295 Rokeby Road
    Suite 1
    SubiacoWA6008
    AUS

    T: +61 865552950

    E: [email protected]

    https://www.argentbiopharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    30 June 2026

    Employees

Stocks News & Analysis

stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.
stocks

Netflix: A business that’s nearly flawless

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks

Trump’s US dollar assault is fuelling CBA’s rise

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,937.5041.90-0.47%
CAC 407,818.2832.15-0.41%
DAX 4024,295.9355.110.23%
Dow JONES (US)44,693.91316.38-0.70%
FTSE 1009,138.3776.880.85%
HKSE25,383.07284.11-1.11%
NASDAQ21,057.9637.940.18%
Nikkei 22541,450.36375.98-0.90%
NZX 50 Index12,855.1049.970.39%
S&P 5006,363.354.440.07%
S&P/ASX 2008,670.1039.30-0.45%
SSE Composite Index3,593.3812.35-0.34%

Market Movers